Familial dysautonomia

Detection of the IKBKAP IVS20+6T → C and R696P mutations and frequencies among Ashkenazi Jews

Jianli Dong, Lisa Edelmann, Asghar M. Bajwa, Ruth Kornreich, Robert J. Desnick

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy that occurs almost exclusively in the Ashkenazi Jewish (AJ) population. Mutations in the IκB kinase complex-associated protein (IKB-KAP) gene cause FD. Two IKBKAP mutations, IVS20+6T → C and R696P, have been identified in FD patients of AJ descent. The splice site mutation IVS20+6T → C is responsible for > 99.5% of known AJ patients with FD, and haplotype analyses were consistent with a common founder. In contrast, the R696P mutation has been identified in only a few AJ patients. To facilitate carrier detection, a single PCR and allele-specific oligonucleotide (ASO) hybridization assay was developed to facilitate the detection of both the IVS20+6T → C and R696P mutations. Screening of 2,518 anonymous AJ individuals from the New York metropolitan area revealed a carrier frequency for IVS20+6T → C of 1 in 32 (3.2%; 95% CI, 2.5-3.9%), similar to the previously estimated carrier frequency (3.3%) based on disease incidence. No carrier was identified for the R696P lesion, indicating that the mutation was rare in this population (< 1 in 2,500). This sensitive and specific assay should facilitate carrier screening for FD mutations in the AJ community, as well as postnatal diagnostic testing.

Original languageEnglish (US)
Pages (from-to)253-257
Number of pages5
JournalAmerican Journal of Medical Genetics
Volume110
Issue number3
DOIs
StatePublished - Jul 1 2002
Externally publishedYes

Fingerprint

Familial Dysautonomia
Jews
Mutation Rate
Mutation
Oligonucleotides
Haplotypes
Population
Phosphotransferases
Alleles
Polymerase Chain Reaction
Incidence

Keywords

  • Allele-specific oligonucleotide hybridization
  • Ashkenazi Jewish population
  • Familial dysautonomia
  • IKBKAP

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Familial dysautonomia : Detection of the IKBKAP IVS20+6T → C and R696P mutations and frequencies among Ashkenazi Jews. / Dong, Jianli; Edelmann, Lisa; Bajwa, Asghar M.; Kornreich, Ruth; Desnick, Robert J.

In: American Journal of Medical Genetics, Vol. 110, No. 3, 01.07.2002, p. 253-257.

Research output: Contribution to journalArticle

Dong, Jianli ; Edelmann, Lisa ; Bajwa, Asghar M. ; Kornreich, Ruth ; Desnick, Robert J. / Familial dysautonomia : Detection of the IKBKAP IVS20+6T → C and R696P mutations and frequencies among Ashkenazi Jews. In: American Journal of Medical Genetics. 2002 ; Vol. 110, No. 3. pp. 253-257.
@article{3c5608fa2d5f48b88926a39ae80ccb60,
title = "Familial dysautonomia: Detection of the IKBKAP IVS20+6T → C and R696P mutations and frequencies among Ashkenazi Jews",
abstract = "Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy that occurs almost exclusively in the Ashkenazi Jewish (AJ) population. Mutations in the IκB kinase complex-associated protein (IKB-KAP) gene cause FD. Two IKBKAP mutations, IVS20+6T → C and R696P, have been identified in FD patients of AJ descent. The splice site mutation IVS20+6T → C is responsible for > 99.5{\%} of known AJ patients with FD, and haplotype analyses were consistent with a common founder. In contrast, the R696P mutation has been identified in only a few AJ patients. To facilitate carrier detection, a single PCR and allele-specific oligonucleotide (ASO) hybridization assay was developed to facilitate the detection of both the IVS20+6T → C and R696P mutations. Screening of 2,518 anonymous AJ individuals from the New York metropolitan area revealed a carrier frequency for IVS20+6T → C of 1 in 32 (3.2{\%}; 95{\%} CI, 2.5-3.9{\%}), similar to the previously estimated carrier frequency (3.3{\%}) based on disease incidence. No carrier was identified for the R696P lesion, indicating that the mutation was rare in this population (< 1 in 2,500). This sensitive and specific assay should facilitate carrier screening for FD mutations in the AJ community, as well as postnatal diagnostic testing.",
keywords = "Allele-specific oligonucleotide hybridization, Ashkenazi Jewish population, Familial dysautonomia, IKBKAP",
author = "Jianli Dong and Lisa Edelmann and Bajwa, {Asghar M.} and Ruth Kornreich and Desnick, {Robert J.}",
year = "2002",
month = "7",
day = "1",
doi = "10.1002/ajmg.10450",
language = "English (US)",
volume = "110",
pages = "253--257",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Familial dysautonomia

T2 - Detection of the IKBKAP IVS20+6T → C and R696P mutations and frequencies among Ashkenazi Jews

AU - Dong, Jianli

AU - Edelmann, Lisa

AU - Bajwa, Asghar M.

AU - Kornreich, Ruth

AU - Desnick, Robert J.

PY - 2002/7/1

Y1 - 2002/7/1

N2 - Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy that occurs almost exclusively in the Ashkenazi Jewish (AJ) population. Mutations in the IκB kinase complex-associated protein (IKB-KAP) gene cause FD. Two IKBKAP mutations, IVS20+6T → C and R696P, have been identified in FD patients of AJ descent. The splice site mutation IVS20+6T → C is responsible for > 99.5% of known AJ patients with FD, and haplotype analyses were consistent with a common founder. In contrast, the R696P mutation has been identified in only a few AJ patients. To facilitate carrier detection, a single PCR and allele-specific oligonucleotide (ASO) hybridization assay was developed to facilitate the detection of both the IVS20+6T → C and R696P mutations. Screening of 2,518 anonymous AJ individuals from the New York metropolitan area revealed a carrier frequency for IVS20+6T → C of 1 in 32 (3.2%; 95% CI, 2.5-3.9%), similar to the previously estimated carrier frequency (3.3%) based on disease incidence. No carrier was identified for the R696P lesion, indicating that the mutation was rare in this population (< 1 in 2,500). This sensitive and specific assay should facilitate carrier screening for FD mutations in the AJ community, as well as postnatal diagnostic testing.

AB - Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy that occurs almost exclusively in the Ashkenazi Jewish (AJ) population. Mutations in the IκB kinase complex-associated protein (IKB-KAP) gene cause FD. Two IKBKAP mutations, IVS20+6T → C and R696P, have been identified in FD patients of AJ descent. The splice site mutation IVS20+6T → C is responsible for > 99.5% of known AJ patients with FD, and haplotype analyses were consistent with a common founder. In contrast, the R696P mutation has been identified in only a few AJ patients. To facilitate carrier detection, a single PCR and allele-specific oligonucleotide (ASO) hybridization assay was developed to facilitate the detection of both the IVS20+6T → C and R696P mutations. Screening of 2,518 anonymous AJ individuals from the New York metropolitan area revealed a carrier frequency for IVS20+6T → C of 1 in 32 (3.2%; 95% CI, 2.5-3.9%), similar to the previously estimated carrier frequency (3.3%) based on disease incidence. No carrier was identified for the R696P lesion, indicating that the mutation was rare in this population (< 1 in 2,500). This sensitive and specific assay should facilitate carrier screening for FD mutations in the AJ community, as well as postnatal diagnostic testing.

KW - Allele-specific oligonucleotide hybridization

KW - Ashkenazi Jewish population

KW - Familial dysautonomia

KW - IKBKAP

UR - http://www.scopus.com/inward/record.url?scp=0036644252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036644252&partnerID=8YFLogxK

U2 - 10.1002/ajmg.10450

DO - 10.1002/ajmg.10450

M3 - Article

VL - 110

SP - 253

EP - 257

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -